No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Edward Sellers?

Dr. Edward M. Sellers

HQ Phone: (416) 648-2817

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

DL Global Partners Inc

Suite 100 78 Baby Point Cres.

Toronto, Ontario M6S 2C1


Company Description

DL Global Partners Inc. is an international consortium of consultants, key opinion leaders and services supporting drug and device development for disorders of the brain. We are the recognized scientific and opinion leaders in abuse potential assessment a ... more

Find other employees at this company (2)

Background Information

Employment History

President and Chief Executive Officer

DecisionLine Clinical Research Corporation


Professor Emeritus, Pharmacology, Medicine and Psychiatry
University of Toronto

ValleVista Natural Health Inc.

Advisory Board Member
ElMindA Ltd

Board Member
University of Toronto Medical Journal


Faculty of Medicine

Harvard University

University of Toronto

H.L. Kaplan PhD




Web References (159 Total References)

Patricia Morley-Forster,MD, Joseph ... [cached]

Patricia Morley-Forster,MD, Joseph Pergolizzi,MD , Edward Sellers,MD . Mitigating the Risks of Addiction, Abuse, and Diversion Undergraduate Pain Management Curricula College on Problems of Drug Dependence 2012

Peter J. Perrino, MS, Salvatore V. ... [cached]

Peter J. Perrino, MS, Salvatore V. Colucci, MS, Megan Shram, PhD, Cynthia Bartlett, MMath, Edward M. Sellers, MD, PhD, FRCPC, Yi Wang, PhD, MPH, Stephen C. Harris, MD. Relative Attractiveness of Oxycodone/Naloxone (OXN): Comparative Assessment of Tampering Potential and Recreational Drug User Preferences for Different Opioid Formulations.

presented by Ed Sellers as part of the Epidemiology Workshop on Post-Marketing Studies of Abuse Detrrent Products. CPDD June 2013
New Guidance: Two Steps Forward or One Step Back? Presented by Ed Sellers at the WORKSHOP: ASSESSMENT OF ABUSE DETERRENT AND TAMPER RESISTANT TECHNOLOGIES. CPDD June 2013
"Assessment of the predictive value of in vitro and human abuse potential testing in relation to the post-marketing impact of ADF: A review of the OxyContin case study. Presented by Ed Sellers at the "Abuse Deterrence Formulation Science Meeting - Discussion of the FDA Draft Guidance for Industry: Abuse Deterrent Opioids - Evaluation and Labeling" sponsored by the Cross-Company Abuse Liability Consortium .September 30 and October 1, 2013, Marriott Conference Center in Bethesda, Maryland.
Myroslava K Romach, Edward M Sellers. Explicit Claims for Tamper Resistance: FDA Draft Guidance for Abuse Deterrent Opiates European College of Neuropsychopharmacology October 2013

Myroslava K. Romach MSc, MD, FRCPC, ... [cached]

Myroslava K. Romach MSc, MD, FRCPC, Edward M. Sellers MD, PhD, FRCPC, FACP

Edward M Sellers MD, PhD, FRCPC, FACP
Myroslava K. Romach MSc, MD, FRCPC, Edward M. Sellers MD, PhD, FRCPC, FACP
Edward M Sellers MD, PhD, FRCPC, FACP
Edward M Sellers MD, PhD, FRCPC, FACP Canadian Pharmaceutical Society

Edward M. Sellers, MD, PhD, ... [cached]

Edward M. Sellers, MD, PhD, FRCPC, FACP President and Principal, DL Global Partners Inc.

An internationally recognized authority on clinical psychopharmacology, pharmacogenetics and smoking, abuse liability assessment and substance abuse. Dr. Sellers has been active in basic and applied science for over 40 years. During this time, he has published more than 350 peer reviewed papers and has been cited more than 26,000 times. He has a broad base of experience as an academic, hospital and CRO industry executive. During his career he has made not only pivotal scientific contributions but also, through his leadership and ability to problem solve, has been instrumental in successfully building programs, units and businesses. He is a founder of DecisionLine Clinical Research, Nicogen Inc. and ValleVista Natural Health Inc. As an independent consultant he has worked with academic institutions, hospitals, government agencies, investors and biopharmaceutical and device companies achieving a deep understanding of their needs. Areas of current focus include accelerating early stage drug development through new methods, optimizing strategies to assess abuse potential of new and re-formulated drugs and regulatory risk management and application of abuse liability methodology to modified risk tobacco related products.
After receiving his MD (Toronto 1965), PhD (Harvard 1971) and Internal Medicine specialty certification in both the United States and Canada (1972), Dr. Sellers began his scientific career at the University of Toronto in 1972 and rapidly rose to the rank of full Professor as he established the world's foremost clinical psychopharmacology unit which trained many of today's leaders in the field. During this period he also became responsible for the operations of the Clinical Institute of the Addiction Research Foundation, one of the world's largest and best known research and treatment organizations in the substance abuse field. With increasingly senior appointments at the University of Toronto, for a period of five years he was responsible for all of the academic programs at the Faculty of Medicine University of Toronto.
In 1997, he co-founded and served as President and CEO of DecisionLine Clinical Research Corporation which grew to be a world leading early stage CRO focused on CNS drug development with over 80 beds and 220 employees and 75 international clients until acquired in 2008 by Kendle International.
In 2010, he founded DL Global Partners Inc. He sits on numerous Scientific Advisory Boards of pharmaceutical and device companies and recently chaired the Scientific Advisory Panel on Opiate Analgesic Abuse for the Therapeutic Products Directorate, Health Canada.
Dr. Sellers has received numerous awards including the Rawls Palmer Progress in Medicine Award (1987 ASCPT); Nathan B. Eddy Award 2012 CPDD; Oscar B Hunter Award (2014 ASCPT).

Edward M. ... [cached]

Edward M. Sellers President and Principal DL Global Partners Inc.

Similar Profiles

Other People with this Name

Other people with the name Sellers

Robert Sellers
Janus Capital Group Inc.

Sharon Sellers
Keller Williams Realty Inc.

Joey Sellers
Saddleback College

David Sellers
LGE Corporation

Jack Sellers
The Stellar Group

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory